LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA – Allogene Therapeutics, Inc. Transaction History
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA portfolio value:
$2.78M
portfolio value
LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA quarter portfolio value change:
-5.26%
quarter
Allogene Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -15.41% | -47.03K shares | -691K | $10.8 | 258.21K |
| Q2 2022 | share | Decrease | -39.10% | -195.96K shares | -1.08M | $11.4 | 305.25K |
| Q1 2022 | share | Decrease | -49.68% | -494.89K shares | -10.29M | $9.11 | 501.21K |
| Q4 2021 | share | Increase | +8.93% | 81.7K shares | -8.63M | $15.38 | 996.11K |
| Q3 2021 | share | Increase | +18.21% | 140.85K shares | 3.32M | $25.7 | 914.41K |
| Q2 2021 | share | Increase | +44.12% | 236.82K shares | 1.22M | $26.08 | 773.56K |
| Q1 2021 | share | Increase | 0.00% | 536.73K shares | 18.94M | $35.3 | 536.73K |